Cribl to Ingest/Edge Processor Case Study

A leading pharmaceutical company leveraging Splunk faced high operational costs due to Cribl Stream, processing 5TB of data daily. To optimize expenses and streamline data ingestion, they chose to migrate to Splunk’s native Ingest Processor, ensuring seamless integration and long-term cost savings.

1. High Licensing Costs – Cribl’s pricing model was expensive due to high daily ingestion.
2. Complex Data Pipelines – Existing Cribl pipelines handled critical transformations with data optimization logic that reduced ingestion volume maintaing the data value.
3. Knowledge Gap – As Ingest Processor is relatively new, internal teams lacked expertise.
4. Zero Downtime Requirement – Migration needed to be seamless without data loss or service disruption.

1. Assessment & Planning
   • We started by thoroughly analyzing the customer’s existing Cribl pipelines, data flows, and transformation logic. This allowed us to map out a 1:1 pipeline structure in Splunk’s Ingest Processor.
2. Dual-Feed Pipeline Implementation
   • To ensure a risk-free transition, we created dual pipelines:
     • Feed 1: Sent raw, unmodified data of Cribl to Splunk.
     • Feed 2: Applied the necessary transformations in Ingest Processor, mirroring Cribl’s functionality.
3. Testing & Validation
   • Both pipelines were tested side-by-side to ensure:
     • Data integrity and completeness
     • Correct application of transformations and data optimization logic.
     • Performance benchmarks matching or exceeding Cribl
4. Seamless Deployment with No Downtime
   • Once validated, we fully enabled the new pipelines, eliminating the Cribl dependency without downtime.

• Hefty Cost Savings – Migrating 5TB/day to Splunk’s native Ingest Processor significantly reduced licensing costs.
• Seamless Transition – Our expertise ensured a smooth migration with zero disruption.
• Ongoing Training & Support – We provided hands-on training and continued support, enabling the customer’s team to manage Ingest Processor confidently.

By migrating from Cribl to Splunk’s Ingest Processor, the pharma company cut costs, simplified operations, and ensured long-term scalability. With our proven expertise, structured approach, and end-to-end support, they successfully embraced Splunk’s native solution without risk or downtime.

For more information or to discuss how our expertise can benefit your organization, please contact us.